14 Nov 2025 | 5 Mins Read
Natco Pharma sees 0.59% decline in September 2025 net sales
Flipitmoney
Reported Consolidated quarterly numbers for Natco Pharma are: Net Sales at Rs 1,363.00 crore in September 2025 down 0.59% from Rs. 1,371.10 crore in September 2024. Quarterly Net Profit at Rs. 518.40 crore in September 2025 down 23.46% from Rs. 677.30 crore in September 2024. EBITDA stands at Rs. 679.20 crore in September 2025 down 21.76% from Rs. 868.10 crore in September 2024.